Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The variant allele HLA-B*15:02 is strongly associated with greater risk of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in patients treated with carbamazepine or oxcarbazepine. The variant allele HLA-A*31:01 is associated with greater risk of maculopapular exanthema, drug reaction with eosinophilia and systemic symptoms, and SJS/TEN in patients treated with carbamazepine. We summarize evidence from the published literature supporting these associations and provide recommendations for carbamazepine and oxcarbazepine use based on HLA genotypes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847474PMC
http://dx.doi.org/10.1002/cpt.1004DOI Listing

Publication Analysis

Top Keywords

carbamazepine oxcarbazepine
12
variant allele
8
associated greater
8
greater risk
8
patients treated
8
treated carbamazepine
8
clinical pharmacogenetics
4
pharmacogenetics implementation
4
implementation consortium
4
consortium guideline
4

Similar Publications

Antiseizure Medications and Bone Health.

Neurol Ther

September 2025

School of Medicine, Universidad de los Andes, Carrera 7 No 116-05 Of 413, Bogotá, Colombia.

Epilepsy frequently requires treatment with antiseizure medications (ASM). With the progressive rise in life expectancy in this population, patients are more exposed to potential undesirable effects, some of them on bone tissue. Here, we review current knowledge concerning the impact of ASM on bone biology.

View Article and Find Full Text PDF

Evaluation of the LAMP-IDE-AI platform for the detection of the HLA-B*15:02 allele in clinical application.

Pathol Res Pract

October 2025

Changzhou Trendi Medical Technology Co., Ltd, Changzhou, Jiangsu Province, China. Electronic address:

The HLA-B*15:02 allele is strongly associated with adverse drug reactions induced by aromatic antiseizure medications such as carbamazepine and oxcarbazepine. Consequently, it is strongly recommended to test for the presence of the HLA-B*15:02 allele before prescribing these medications. Traditional HLA genotyping methods (e.

View Article and Find Full Text PDF

: The aim of this study was to elucidate the associations between the use of various ASMs and systemic anti-inflammatory effects in a single large cohort using routine blood tests. : Patients who underwent blood tests within three months of their first visit to our clinic were included. The systemic inflammatory index (SII, platelet × neutrophil/lymphocyte ratio), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and fibrinogen-albumin ratio (FAR) were compared across specific ASMs.

View Article and Find Full Text PDF

Objective: To estimate the proportion of individuals with focal epilepsy treated with at least one among carbamazepine (CBZ), oxcarbazepine (OXC), or eslicarbazepine (ESL), who were hospitalized due to hyponatremia-related symptoms in 2024, and to test the hypothesis that there is an association with climatic variables.

Methods: We undertook a prospective study in which people with focal epilepsy treated with at least one of the target drugs and at least one attendance in 2024 formed the study cohort. Individuals who were admitted or seen as outpatients for hyponatremia in 2024 were considered cases and the rest considered controls.

View Article and Find Full Text PDF